tiprankstipranks
Trending News
More News >
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
Advertisement

Monopar Therapeutics Inc (MNPR) Similar Stocks

Compare
546 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Monopar Therapeutics Inc
$84.73
$468.30M
2036.48%
9 Buy
0 Hold
0 Sell
Strong Buy
Cardiff Oncology
$2.10
$138.37M
-17.00%
5 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$5.16
$301.35M
14.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
Verastem
$8.80
$541.60M
224.55%
5 Buy
0 Hold
0 Sell
Strong Buy
Mereo Biopharma Group Plc
$2.05
$325.95M
-53.41%
5 Buy
0 Hold
0 Sell
Strong Buy
Silence Therapeutics
$5.10
$240.89M
-73.02%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MNPR
Monopar Therapeutics Inc
97.21
92.66
2036.48%
CRDF
Cardiff Oncology
2.10
-0.43
-17.00%
VNDA
Vanda
5.16
0.66
14.67%
VSTM
Verastem
8.99
6.22
224.55%
MREO
Mereo Biopharma Group Plc
2.05
-2.35
-53.41%
SLN
Silence Therapeutics
5.20
-14.07
-73.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis